Company Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific Announces Scheduled Presentations At Heart Rhythm Society 2016

[PR Newswire] – MARLBOROUGH, Mass., April 28, 2016 /PRNewswire/ — Boston Scientific (NYSE: BSX) today announced key data, including one late-breaking clinical trial, that will be featured at the 37th Annual Scientific … Read more on this. Boston Scientific Corporation (BSX) , with a current value of $29.56B, opened this morning at $22.07. Shares have traded today between $21.70 and $22.42 per share with the price of the stock fluctuating between $14.18 to $22.42 over the last 52 weeks. BSX shares are currently priced at 20.85x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 6.53x earnings multiple for the same period. In a review of the consensus earnings estimate this quarter, 26 sell-side analysts are looking at $0.26 per share, which would be $0.04 better than the year-ago quarter and a $0.00 sequential decrease. In looking at the bigger picture, the full-year EPS estimate of $1.05 would be a $0.12 better when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $2.02 Billion. If realized, that would be a 9.78% increase over the year-ago quarter. More recently, Nomura Initiated BSX at Buy (Mar 17, 2016). Previously, Sun Trust Rbsn Humphrey Initiated BSX at to Buy. Investors should keep in mind is that the average price target is $22.70, which is 2.85% above where the stock opened this morning. See more in (NYSE:BSX) Similar Articles: Company Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific To Webcast Conference Call Discussing First Quarter 2016 Financial Results On April 27 Company Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2015 Company Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific to Participate in Leerink Partners 2016 Healthcare Conference